Learn

Allison Jones

Home page>Cardiology>Amyloidosis>Virtual journey: ATTR amyloidosis

Virtual journey: ATTR amyloidosis

Written byJameson Kowalczyk

Medically reviewedin March 2025

Description

Heart Failure Heart Health

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Up next

Living with and treating ATTR amyloidosis

Living with and treating ATTR amyloidosis

Recommended for you

Treatment options for hATTR amyloidosisAn overview of TTR stabilizers and gene-silencing therapies for treating hereditary transthyretin (hATTR) amyloidosis.

ATTR cardiomyopathy: gene silencers and gene stabilizersA look at two types of disease-modifying therapies used in the treatment of ATTR cardiomyopathy.

Living with and treating ATTR amyloidosis

5 answers about ATTR amyloidosisHow ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

What are the early symptoms of ATTR?A look at the early symptoms of ATTR peripheral neuropathy and ATTR cardiomyopathy.

Cookies Your privacy choices

Privacy Consumer health data privacy Terms

Copyright Sharecare © 2026